Company scheduled to meet with the FDA in mid-April 2026 to review the results of the Phase 3 EFZO-FIT study and determine the path forward for efzofitimod in pulmonary sarcoidosis. Phase 2 EFZO-CONNE ...

A new paper led by UC San Diego researchers offers an encyclopedic review of research on vagus nerve stimulation for conditions from depression to rheumatoid arthritis, as well as highlighting next ...